-+ 0.00%
-+ 0.00%
-+ 0.00%
Fangsheng Pharmaceutical (603998.SH) passed the drug GMP compliance inspection
Share
Listen to the news

Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) issued an announcement. Recently, the company received two “Pharmaceutical GMP Compliance Inspection Notices” issued by the Hunan Drug Administration. The company obtained pharmaceutical GMP compliance inspection results this time, indicating that the company's relevant production lines meet GMP requirements, which helps the company further enrich the variety of products produced, maintain stable production capacity, and meet market demand.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending